Pennsylvania House Bill HB2117

Pennsylvania 2025-2026 Regular Session

• Introduced: 1/8/26
• Refer: 1/8/26

Caption

In school health services, further providing for definitions, for possession and use of asthma inhalers and epinephrine auto-injectors, for school access to emergency epinephrine and for administration of epinephrine auto-injectors by school bus drivers and school crossing guards.

Impact

The legislative intent behind HB2117 is to improve the response to health emergencies in schools, potentially saving lives by ensuring that staff can quickly access and administer necessary medications such as epinephrine. The bill could have significant implications on state education regulations, ensuring that all schools adhere to the same standards and practices concerning health services. This uniformity could lead to a higher overall standard of care for students in emergency situations, creating a safer school environment.

Summary

House Bill 2117 focuses on enhancing the health services available in schools, specifically relating to asthma management and the administration of epinephrine auto-injectors. The bill proposes clearer definitions regarding the possession and use of these medical devices, aiming to ensure that schools can adequately support students with asthma or those who might experience severe allergic reactions. By setting defined protocols, HB2117 seeks to standardize practices across various educational institutions.

Contention

Although the bill aims to enhance school health services, it might face debates centered around the logistics of implementation and training for school staff on proper administration techniques. There could be concerns from educators regarding the additional responsibilities placed on them, especially for non-medical personnel. Critics may argue whether the resources needed for full compliance are available, particularly in underfunded school districts, creating a potential point of contention as the bill moves forward.